General MedicationsINTRAVENOUSStandard

NEOSTIGMINE METHYLSULFATE

Standard Dose

10MG/10ML (1MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview NEOSTIGMINE METHYLSULFATE is listed in Drugs@FDA under application 216542 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NEOSTIGMINE METHYLSULFATE Form and strength SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML) Sponsor SAGENT PHARMS INC Submission history Latest submission status date: 2023-02-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEOSTIGMINE METHYLSULFATE is listed in Drugs@FDA under application 216542 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NEOSTIGMINE METHYLSULFATE Form and strength SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML) Sponsor SAGENT PHARMS INC Submission history Latest submission status date: 2023-02-17 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.